US 2026/0022089 A1 · QUINONE-DERIVED COMPOUNDS AND USE THEREOF AGAINST LEISHMANIA SPP

Abstract

The present invention relates to quinone-derived compounds with leishmanicidal activity and to the use of same in the pharmaceutical industry, specifically in the field of parasitic diseases. The invention relates specifically to a compound of formula (I), the isomeric forms thereof and the salts of same, wherein R1 and R3 are hydrogen and R2 is selected from the list consisting of cyclopentyl, cycloheptyl, 3-methyl-pentyl and adamantane, or wherein R1 and R2 are hydrogen and R3 is selected from the list consisting of cyclopentyl, cyclohexyl and cycloheptyl.

Claims18

Dependent claims

A compound of formula (I), the isomeric forms thereof and the salts of same,

wherein R1 and R3 are hydrogen and R2 is selected from the list consisting of cyclopentyl, cycloheptyl, and 3-methyl-pentyl;
or wherein R1 and R2 are hydrogen and R3 is selected from the list consisting of cyclopentyl, cyclohexyl and cycloheptyl.

Dependencies are inferred from the claim text.

Facts

Application

18/879,845Filed 22 Jun 2023

Priority

ES P20223058128 Jun 2022

Published

22 Jan 2026

Term ends

Not estimatedThe source records don’t support an estimate.

Classification19 codes

C07C 50/04
With monocyclic quinoid structure: benzoquinones, i.e. C6H4O2
A61K 31/122
Ketones: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 47/06
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…: organic…
A61K 47/32
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates: macromolecular compounds obtained by reactions only involving…

Quinone-derived compounds and use thereof against leishmania spp

Life of this patent

Quinone-derived compounds and use thereof against leishmania spp

Life of this patent

Abstract

Claims18